PALO ALTO, Calif., Sept. 19, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced the first two planned system installations of the company's Edge™ Radiosurgery Suite, a fully integrated dedicated system for performing advanced radiosurgery using new real-time tumor tracking technology and motion management capabilities. "We are pleased to announce the first two installations will be at the Champalimaud Foundation in Lisbon, Portugal and Henry Ford Health System in Detroit, Michigan," says Chris Toth, vice president of marketing for Varian's Oncology Systems business. "Champalimaud Foundation represents our first installation in Europe and Henry Ford Health System our first in North America. The institutions represent and embody clinical excellence and we are thrilled that we get to launch this exciting new platform into clinical use with them." "High-precision stereotactic ablative radiotherapy has evolved into a highly efficient, non-invasive, and low-toxicity method for treating and, in many cases, eradicating tumors, in an ever increasing number of clinical settings," says Carlo Greco, M.D., professor of radiation oncology and director of clinical research at the Champalimaud Centre for the Unknown. "The Edge system has been designed to meet this challenge, providing a very comprehensive platform for delivery of high-precision 4-D adaptive tumor radiotherapy." "At Henry Ford, we've had long-standing multidisciplinary collaborative research teams conducting research into the optimal use of radiosurgery to treat tumors of the spine and brain," says neurosurgeon Steven N. Kalkanis, M.D., director of the Center for Cancer Surgery at Henry Ford Hospital. "The biggest challenge with this type of treatment is that there is no room for error. Millimeters matter. The Edge radiosurgery suite is calibrated for sub-millimeter accuracy. That will help us rest assured that we are doing everything possible to protect normal tissues." "Varian's Edge suite offers clinicians a wide spectrum of capabilities in one smooth end-to-end workflow," said Kolleen Kennedy, president of Varian's Oncology Systems business. "With sub-millimeter accuracy, accelerated treatment speeds, and real-time tracking, we feel the Edge has become the sharpest radiosurgery blade on the market, and we are delighted to be working with the system's early adopters." The Edge Advisory Board Varian is also launching The Edge Advisory Board, in order to partner with thought leaders in radiosurgery, including neuro- and thoracic surgeons as well as radiation oncologists, to support clinical education and advance standards of care.